Conoscenze Home Salute delle persone Conoscenze All Parere Documenti Scienza popolare Interviste Filtra Therapeutic areasCOVID-19Salute digestiva Apply Home Salute delle persone Conoscenze Test of Safety and immunogenicity of a PHH-1V booster dose after different prime vaccination schemes against COVID-19: Phase III clinical trial final results up to one year Home Salute delle persone Conoscenze Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19 Home Salute delle persone Conoscenze Preclinical evaluation of PHH-1V candidate against SARS-CoV-2 in non-human primates Home Salute delle persone Conoscenze Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate Home Salute delle persone Conoscenze Clone of Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate Home Salute delle persone Conoscenze Clone of Clone of Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate Home Salute delle persone Conoscenze Clone of Clone of Clone of Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate Home Salute delle persone Conoscenze Safety and immunogenicity of a recombinant protein RBD fusion heterodimer vaccine against SARS-CoV-2 Home Salute delle persone Conoscenze Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial Carica di più
